UroToday.com· @urotoday · X·· 2 天前评分70
正文 · 机器翻译
围手术期 Pembrolizumab 或 PBO + 新辅助顺铂和吉西他滨用于肌层浸润性 #BladderCancer #MIBC 受试者：双盲、3 期 KEYNOTE-866 研究。由 Jens Bedke 医学博士主讲。#ESMO26 文字报道由 @chavarriagaj 撰写 > https://bit.ly/4epWdbe #Immunotherapy @myESMO
420 浏览 · 5 赞 · 2 转发 · 0 回复
会议摘要
4735O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Perioperative pembrolizumab (pembro) or placebo (pbo) + neoadjuvant cisplatin (cis) and gemcitabine (gem) in participants (pts) with muscle-invasive bladder cancer (MIBC): the double-blind, phase 3 KEYNOTE-866 study
https://esmocongress.esmo.org来源：UroToday.com · x.com